疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

! V6 k4 V5 F" w; ^+ P. ~Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
" e1 Q& y& b6 U" j" j
http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
3 X& C( s1 i) J! g! H/ ^/ x' b- F
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
$ g3 m8 e3 O! V3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
$ |9 f# X/ Y0 y7 H! N4 F9 _! w) u" e6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
* C- ?2 E/ u0 f8 General immunization practices 88
! _6 I1 o2 N. X/ ]SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
12 Diphtheria toxoid 153
4 }+ J5 k( r; H/ M13 Haemophilus influenzae vaccines 167
4 g, L7 u) h# r14 Hepatitis A vaccines 183
% M' }/ `; h2 a& p6 W' q" {' R15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
, A: s1 e/ \( K3 y6 ]17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
7 h  y+ Y$ T2 I6 t7 Y: h  m' m19 Japanese encephalitis vaccines 312
  m7 L  r- k0 T) ~6 A( N. t5 U20 Measles vaccines 352
21 Meningococcal vaccines 388
$ d1 Z7 ?1 f1 j5 s8 P22 Mumps vaccine 419
23 Pertussis vaccines . 447
) r5 @# J, n7 Z* N: [4 y4 c' t/ S24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
% @5 l4 y1 l- b0 g30 Rotavirus vaccines . 669
31 Rubella vaccine 688
: y2 D6 f* C5 y( V% C32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
: f$ ?7 }3 m+ \8 z6 j3 X34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
1 N) M" o5 P2 Y4 Z5 L. o36 Typhoid fever vaccines 812
4 r% l; [# R0 j: A$ p37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
$ o5 V% w. ~7 [9 m) F# ~0 }3 RSECTION 3: Vaccines in development and new vaccine strategies
- q2 Y& ~& I4 ]. T& q5 w41 Biodefense and special pathogen vaccines 1008
: H0 {+ [2 `# U1 G1 ]+ x1 ]42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
) d0 }# E- z3 I3 l. b) o( t9 d- [47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
0 w: s/ c1 k) s8 C4 k* g50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
6 H) O$ v8 m) U0 r% v, c+ v52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
2 y" }1 x6 O1 N54 Noninfectious disease vaccines 1138
+ |  h& X' J' D* w$ r' x3 T55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
9 M# Z1 d, X6 c% C& d' N" C56 Parasitic disease vaccines 1154
$ |  h" J/ F& T6 z5 G57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
# Y) z- k# J" Z6 a: y" E/ X) W& H4 t6 m60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
6 S2 I/ E! j: p( p4 P64 Vaccination of human immunodeficiency virus-infected persons 1257
) f+ O2 n) i  o2 y2 S5 m" L# I; e/ b( S65 Vaccines for international travel 1270
# \& u; m$ E$ L66 Vaccines for health care personnel 1290
4 ]' e! N7 T' L6 h, gSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
* y$ j8 X3 ]: b+ ?; m68 Immunization in Europe . 1334
" p8 |! ?/ D1 D69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
9 x6 `( D& U2 O2 _72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
9 j$ N3 r# `- O$ S' e, X76 Vaccine safety 1464
77 Legal issues . 1481
) e: d. x' F2 \: E; ?5 U+ g7 ]$ M6 A78 Ethics 1508



8 Q' m$ N# z+ @* z9 H

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

! c9 C) M( t% M# Z! e- a" P$ w' [Vaccines, 6th Edition
- y: Q  z5 F, M
3 s" q3 w: X& S- S* V% wApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
! s& n. V3 [8 n9 L# N" m
http://yun.baidu.com/share/link? ... 1&uk=3810996606
- [1 h# [; `# `: c+ X3 U$ G) {
) z1 p+ g6 u) I# J1 fSECTION 1: General aspects of vaccination
+ W: L6 |/ k9 G' v" b1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
: g9 B' `8 `8 R8 j0 ]  c4 Vaccine manufacturing 44
7 t9 ^+ d& d; U, J0 v7 b5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
: {8 D6 z$ r' n. T4 T2 R6 [licensed vaccines 71
( s6 ~4 y, z$ e6 e5 b1 e2 A, e7 Passive immunization 80
8 General immunization practices 88
. J6 l5 W$ v4 ]6 ~9 R& HSECTION 2: Licensed vaccines
7 O" @; R! n' a- @+ C. q1 J9 Adenovirus vaccines 113
+ \' u" u* B* v& v& u5 O! H  c10 Anthrax vaccines 127
& e+ X/ z/ a0 Z* v11 Cholera vaccines 141
1 y# c. S; l, ^" \8 @3 O: w2 L6 o12 Diphtheria toxoid 153
7 d, Y' m8 r( ]13 Haemophilus influenzae vaccines 167
8 h" ?+ q( C( }: W7 H- I14 Hepatitis A vaccines 183
# r* z' x4 P1 }. ~15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
8 I7 c* J9 `; b8 @. ^! N" I' I17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
/ M" L( H* J* J* U2 \19 Japanese encephalitis vaccines 312
7 B4 |2 G  P+ b" w20 Measles vaccines 352
21 Meningococcal vaccines 388
4 I5 W! [8 Q  A' N& Y; s22 Mumps vaccine 419
23 Pertussis vaccines . 447
" ~- C; X3 N; ]5 \  n9 W; ]24 Plague vaccines 493
- B" w% H* U2 ?& k* K' b% _25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
+ a* H$ t9 h% d26 Pneumococcal polysaccharide vaccines 542
8 I/ D. q" k9 U, ?27 Poliovirus vaccine-inactivated . 573
, {8 q" N1 `3 \28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
3 B8 c% Y/ Y: d) @30 Rotavirus vaccines . 669
& I  H  p: G( ^; k' z% P" {7 @31 Rubella vaccine 688
1 E( Z# N: ^2 t- F32 Smallpox and vaccinia 718
9 v) K. a* t/ G. Y33 Tetanus toxoid 746
% O' S6 G+ h+ F1 k34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
0 m& f- K$ Q9 W" J( @" B3 \$ d36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
$ O0 a* l- J5 I. v+ G' L/ `44 Dengue vaccines 1042
5 V3 F0 g! l# @45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
  W0 i$ |! ^& f* Z7 z4 t47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
# j- w& Q5 X' {49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
) e, \! l6 L: I  n52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
0 \  \# G0 i% ]) ?7 \: w, Y54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
5 e6 j; _5 G9 N* q# G8 B59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
& r" Z% _0 c7 r; v. o1 V8 c61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
, j! @  V$ y# ^0 @- I- iSECTION 4: Vaccination of special groups
+ _6 M+ C; A6 O/ L* \1 ?63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
9 ^. t6 P) }/ i. l  d+ P65 Vaccines for international travel 1270
# l" v) ]$ L/ o' K% H) m) c66 Vaccines for health care personnel 1290
6 l6 e- h- ]8 @# b, nSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
4 Z2 g( d: c) j68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
& v2 H3 }' F9 J- d6 p73 Regulation and testing of vaccines 1427
9 _# E5 n5 `( P8 M4 R8 D74 Regulation of vaccines in Europe 1447
2 I' }  s& E& I' [  C75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
# E; b( \3 n% {+ r$ h77 Legal issues . 1481
78 Ethics 1508
! Y' l9 u- N5 n7 A1 [) `
& J. {/ \% O$ |4 h1 d

casarett

Vaccines, 6e, 2012

Hardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
Language: English
! b9 X4 P( y/ g; M! p( k- oISBN-10: 1455700908
# r' ?' d8 h- MSize: 52.3mb (original pdf)

: r3 p9 E$ y0 Y  C. X; a" s4 D5 X2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
, c: r# p8 n. J
Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
  m% {7 z7 h: h) ?6 KUpdate your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
  x) d/ M8 P. U4 q4 O( e8 ZAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
. ~8 j! y. ]  R- K* zClearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
# B+ B9 O- Y; ~' q' ]2 rStay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

Download link: http://pan.baidu.com/s/1i5NxwLR
4 k/ v, f6 _4 D& t) @5 H+ mCode for downloading: dv96
# E+ r+ s0 A' d2 b$ C+ }9 g